Donepezil provides positive effects to patients treated with gabapentin for neuropathic pain: An exploratory study

Acta Anaesthesiologica Scandinavica

Volumn 58, Issue 1, 2014, Pages 61-73

  Basnet, A ^a   Butler, S ^b   Honore P H ^a   Butler, M ^b   Gordh, T E ^b   Kristensen, K ^c   Bjerrum, O J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; GABAPENTIN; VENLAFAXINE;

ADD ON THERAPY; ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONFUSION; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXPLORATORY RESEARCH; FEMALE; HUMAN; LOADING DRUG DOSE; MALE; MIDDLE AGED; MONOTHERAPY; MOOD DISORDER; MUSCLE CRAMP; NAUSEA AND VOMITING; NEUROPATHIC PAIN; OPEN STUDY; PAIN ASSESSMENT; POSTTRAUMATIC PAIN; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT DURATION;

ADULT; AGED; ALGORITHMS; AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; CYCLOHEXANOLS; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INDANS; MALE; MIDDLE AGED; NEURALGIA; NEUROPROTECTIVE AGENTS; PAIN MEASUREMENT; PIPERIDINES; QUALITY OF LIFE; SAMPLE SIZE;

EID: 84890547942     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12218     Document Type: Article

References (40)

1. Harden N, Cohen M,. Unmet needs in the management of neuropathic pain. J Pain Symptom Manage 2003; 25: S12-17.
2. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpää ML, Kent JL, Krane EJ, Lebel AA, Levy RM, Mackey SC, Mayer J, Miaskowski C, Raya SN, Rice AS, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD,. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85: S3-14.
3. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E,. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280: 1831-1836.
4. Gordh TE, Stubhaug A, Jensen TS, Arnèr S, Biber B, Boivie J, Mannheimer C, Kalliomäki J, Kalso E,. Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study. Pain 2008; 138: 255-266.
5. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L,. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837-1842.
6. Gilron I, Max MB,. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother 2005; 5: 823-830.
7. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P,. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153-1169.
8. Taylor CP,. Mechanisms of analgesia by gabapentin and pregabalin-calcium channel alpha2-delta [Cavalpha2-delta] ligands. Pain 2009; 142: 13-16.
9. Hayashida K, Obata H, Nakajima K, Eisenach JC,. Gabapentin acts within the locus coeruleus to alleviate neuropathic pain. Anesthesiology 2008; 109: 1077-1084.
10. Tanabe M, Takasu K, Takeuchi Y, Ono H,. Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J Neurosci Res 2008; 86: 3258-3264.
11. Folkesson A, Honore PH, Andersen LM, Kristensen P, Bjerrum OJ,. Low dose of donepezil improves gabapentin analgesia in the rat spared nerve injury model of neuropathic pain: single and multiple dosing studies. J Neural Transm 2010; 117: 1377-1385.
12. Hayashida K, Parker R, Eisenach JC,. Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil. Anesthesiology 2007; 106: 1213-1219.
13. Hartvig P, Gillberg PG, Gordh T, Post C,. Cholinergic mechanisms in pain and analgesia. Trends Pharmacol Sci 1989; (Suppl): 75-79.
14. Bouaziz H, Tong C, Eisenach JC,. Postoperative analgesia from intrathecal neostigmine in sheep. Anesth Analg 1995; 80: 1140-1144.
15. Eisenach JC, Detweiler DJ, Tong C, D'Angelo R, Hood DD,. Cerebrospinal fluid norepinephrine and acetylcholine concentrations during acute pain. Anesth Analg 1996; 82: 621-626.
16. Hood DD, Mallak KA, James RL, Tuttle R, Eisenach JC,. Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition. J Pharmacol Exp Ther 1997; 282: 86-92.
17. Petersson J, Gordh TE, Hartvig P, Wiklund L,. A double-blind trial of the analgesic properties of physostigmine in postoperative patients. Acta Anaesthesiol Scand 1986; 30: 283-288.
18. Hwang JH, Hwang KS, Leem JK, Park PH, Han SM, Lee DM,. The antiallodynic effects of intrathecal cholinesterase inhibitors in a rat model of neuropathic pain. Anesthesiology 1999; 90: 492-499.
19. Lavand'homme P, Pan HL, Eisenach JC,. Intrathecal neostigmine, but not sympathectomy, relieves mechanical allodynia in a rat model of neuropathic pain. Anesthesiology 1998; 89: 493-499.
20. Pöyhiä R, Xu M, Kontinen VK, Paananen S, Kalso E,. Systemic physostigmine shows antiallodynic effects in neuropathic rats. Anesth Analg 1999; 89: 428-433.
21. Caldwell JE,. Clinical limitations of acetylcholinesterase antagonists. J Crit Care 2009; 24: 21-28.
22. Jackson S, Ham RJ, Wilkinson D,. The safety and tolerability of donepezil in patients with Alzheimer's disease. Br J Clin Pharmacol 2004; 58: 1-8.
23. Heeremans EH, Proost JH, Eleveld DJ, Absalom AR, Struys MMRF,. Population pharmacokinetics and pharmacodynamics in anesthesia, intensive care and pain medicine. Curr Opin Anaesthesiol 2010; 23: 479-484.
24. Shafer SL, Struys MMRF,. Mixed effect modelling in analgesia trials. Anesth Analg 2008; 107: 9-10.
25. Aasvang EK, Hansen JB, Malmstrøm J, Asmussen T, Gennevois D, Struys MMRF, Kehlet H,. The effect of wound instillation of a novel purified capsaicin formulation on postherniotomy pain: a double-blind, randomised, placebo-controlled study. Anesth Analg 2008; 107: 282-291.
26. Melzack R,. The short-form McGill Pain Questionnaire. Pain 1987; 30: 191-197.
27. Burckhardt CS, Bjelle A,. A Swedish version of the short-form McGill Pain Questionnaire. Scand J Rheumatol 1994; 23: 77-81.
28. Ware JE, Sherbourne CD,. The MOS 36-item short-form health survey (SF-36). I. Conceptual frame work and item selection. Med Care 1992; 30: 473-483.
29. Sullivan M, Karlsson J,. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 1998; 51: 1105-1113.
30. Beal SL, Sheiner LB,. NONMEM users guides (1989-1992). Ellicott City, Icon Development Solutions, 1992.
31. Jonsson EN, Karlsson MO,. Xpose-an S-PLUS based population pharmacokinetic-pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 1999; 58: 51-64.
32. Hayashida KI, Bynum T, Vincler M, Eisenach JC,. Inhibitory M2 muscarinic receptors are upregulated in both axotomized and intact small diameter dorsal root ganglion cells after peripheral nerve injury. Neuroscience 2006; 140: 259-268.
33. Matthews JN, Altmann DG, Campbell JN, Royston P,. Analysis of serial measurements in medical research. BMJ 1990; 300: 230-235.
34. Backonja M, Glanzman RL,. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003; 25: 81-104.
35. Katz J, Finnerup NB, Dworkin RH,. Clinical trial outcome in neuropathic pain: relationship to study characteristics. Neurology 2008; 70: 263-272.
36. Dworkin RH, Katz J, Gitlin MJ,. Placebo responses in clinical trials of depression and its implications for research on chronic neuropathic pain. Neurology 2005; 65: S7-19.
37. Hrobjartsson A, Gøtzsche PC,. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010; 1: CD003974. doi: 10.1002/14651858.CD003974.pub3
38. Bjerrum OJ, Bjerrum HJ,. Donepezil anvendt ved neuropatiske smerte [In Danish]. Ugeskr Læger 2013; 42: 2493-2494.
39. Chiari A, Tobin JR, Pan HL, Hood DD, Eisenach JC,. Sex differences in cholinergic analgesia I: a supplemental nicotinic mechanism in normal females. Anesthesiology 1999; 91: 1447-1454.
40. Lavand'homme PM, Eisenach JC,. Sex differences in cholinergic analgesia II: differing mechanisms in two models of allodynia. Anesthesiology 1999; 91: 1455-1461.